Aquestive TherapeuticsAQST
那斯達克 · USD
6.32
+0.09
(+1.44%)
收盤 12/12 04:58 (UTC+8)
盤後
6.33
+0.01
(+0.16%)
12/12 04:58 (UTC+8)
Aquestive TherapeuticsAQST
6.32
+0.09
(+1.44%)
財務數據
損益表
- 0.13
- 0.13
- 0.13
- 0.12
- 0.20
- 0.14
- 0.12
- 0.09
- 0.10
- 0.13
- 18.92
- -1.80
- 1.57
- -8.73
- 66.76
- -32.62
- -12.37
- -26.52
- 14.71
- 28.03
- 營業收入(億)
- 季增長率(%)
單位：美元千元
2025/Q3 | 2025/Q2 | 2025/Q1 | 2024/Q4 | 2024/Q3 | 2024/Q2 | 2024/Q1 | 2023/Q4 | 2023/Q3 | 2023/Q2 | |
營業收入淨額 | 12,807 | 10,003 | 8,720 | 11,867 | 13,542 | 20,099 | 12,053 | 13,206 | 13,002 | 13,241 |
營業成本 | 4,506 | 4,561 | 3,652 | 4,520 | 4,437 | 4,526 | 4,389 | 4,679 | 4,798 | 6,617 |
營業毛利 | 8,301 | 5,442 | 5,068 | 7,347 | 9,105 | 15,573 | 7,664 | 8,527 | 8,204 | 6,624 |
營業費用 | 19,780 | 16,810 | - | - | - | - | - | 12,438 | 10,581 | 10,833 |
研發費用 | 4,530 | 4,105 | 5,361 | 4,917 | 5,269 | 4,162 | 5,932 | 2,888 | 3,196 | 3,473 |
推銷及管理費用 | 15,250 | 12,705 | 19,072 | 16,009 | 12,126 | 11,356 | 10,689 | 9,550 | 7,385 | 7,360 |
非經常性項目費用 | - | - | - | - | - | - | - | - | - | - |
其他營業費用 | - | - | - | - | - | - | - | - | - | - |
營業利益 | -11,479 | -11,368 | -19,365 | -13,579 | -8,290 | 55 | -8,957 | -3,911 | -2,377 | -4,209 |
其他收入及費用 | 306 | 2,096 | 713 | 734 | 979 | 1,395 | 329 | -864 | -14,642 | -14,513 |
利息費用 | 4,273 | 4,276 | 4,278 | 4,224 | 4,198 | 4,195 | 4,200 | 3,235 | 1,312 | 1,428 |
稅前純益 | -15,446 | -13,548 | -22,930 | -17,069 | -11,509 | -2,745 | -12,828 | -8,010 | -2,175 | -5,508 |
所得稅 | - | - | - | -14 | - | - | - | 101 | -140 | 284 |
稅後純益 | -15,446 | -13,548 | -22,930 | -17,055 | -11,509 | -2,745 | -12,828 | -8,111 | -2,035 | -5,792 |
基本每股稅後盈餘(元) | -0.14 | -0.14 | -0.24 | -0.19 | -0.13 | -0.03 | -0.17 | - | -0.03 | -0.10 |
稀釋每股稅後盈餘(元) | -0.14 | -0.13 | -0.24 | -0.19 | -0.13 | -0.02 | -0.17 | -0.13 | -0.04 | -0.07 |
基本平均股數(千股) | 110584.00 | 99326.00 | 95497.00 | 91199.00 | 91082.00 | 90911.00 | 73614.00 | - | 64678.00 | 57350.00 |
稀釋平均股數(千股) | 110584.00 | 99326.00 | 95497.00 | 91199.00 | 91082.00 | 90911.00 | 73614.00 | - | 64678.00 | 57350.00 |
還原基本每股稅後盈餘(元) | -0.14 | -0.14 | -0.24 | -0.19 | -0.13 | -0.03 | -0.17 | - | -0.03 | -0.10 |
還原稀釋每股稅後盈餘(元) | -0.14 | -0.13 | -0.24 | -0.19 | -0.13 | -0.02 | -0.17 | -0.13 | -0.04 | -0.07 |
還原基本平均股數(千股) | 110,584 | 99,326 | 95,497 | 91,199 | 91,082 | 90,911 | 73,614 | - | 64,678 | 57,350 |
還原稀釋平均股數(千股) | 110,584 | 99,326 | 95,497 | 91,199 | 91,082 | 90,911 | 73,614 | - | 64,678 | 57,350 |
EBITDA(千元) | -8,286 | -6,384 | -15,763 | -9,999 | -4,479 | 4,324 | -5,748 | -2,510 | -540 | -3,732 |